FIGO GRADE 1 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Clinical trials for FIGO GRADE 1 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new FIGO GRADE 1 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for FIGO GRADE 1 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo trial aims to slow advanced uterine cancer
Disease control OngoingThis study is testing whether adding a new drug called ipatasertib to an existing hormone therapy (megestrol acetate) is more effective at controlling advanced endometrial cancer that has returned or spread. The trial will first find the safest dose of the combination, then compa…
Matched conditions: FIGO GRADE 1 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 03:20 UTC
-
New hope for Tough-to-Treat ovarian cancers in early trial
Disease control OngoingThis early-stage study is testing a new two-drug combination for women with ovarian cancer that has returned after previous treatment. The main goal is to find the safest and most effective dose of an experimental pill (peposertib) when given with a standard chemotherapy drug. Re…
Matched conditions: FIGO GRADE 1 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New trial tests Two-Drug combo to fight uterine cancer without surgery
Disease control OngoingThis study is testing whether a hormone-releasing intrauterine device (IUD) works better alone or combined with an oral drug called everolimus to treat early-stage uterine cancer or a serious pre-cancerous condition. The goal is to see if this approach can control or eliminate th…
Matched conditions: FIGO GRADE 1 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Video calls bring strength training to rural cancer survivors
Symptom relief OngoingThis study is testing whether a 10-week home exercise program, delivered remotely via video calls, can improve physical function and quality of life for survivors of early-stage endometrial cancer. It focuses on participants who live in rural areas or are from historically unders…
Matched conditions: FIGO GRADE 1 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Mar 25, 2026 14:09 UTC
-
New test aims to predict which uterine cancers come back
Knowledge-focused OngoingThis study aims to find out if a molecular test can predict whether low-risk endometrial cancer will return after a patient has surgery to remove it. Researchers are studying 518 patients who are scheduled for a hysterectomy. They will analyze tumor tissue and track patients for …
Matched conditions: FIGO GRADE 1 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 04, 2026 03:21 UTC